Académique Documents
Professionnel Documents
Culture Documents
Leptospirosis
an infectious disease.
characterized by a broad spectrum of clinical manifestations (from inapparent
infection to fulminant, fatal disease).
Mild form:
present as an influenza-like illness with headache and myalgias.
Require special media and conditions for growth; it may take weeks for
cultures to become positive
Morphology
The Leptospira appear tighly coiled thin flexible Spritochetes
Fine spiral of 0.1 – 0.2 microns
One end appears bent forms a hook.
Actively motile
Seen best with dark field Microscopy.
Establish a symbiotic relationship with their host and can persist in the renal
tubules for years
Some serovars are associated with particular animals:
icterohaemorrhagiae/copenhageni : rats
Grippotyphosa: voles
Hardjo:cattle
Canicola :dogs
pomona : pigs.
Transmission
May follow direct contact with:
urine
blood
or tissue from an infected animal
exposure to a contaminated environment
human-to-human transmission is rare.
Excreted in the urine and can survive in water for many months
Water is an important vehicle in their transmission.
Epidemics may result from exposure to flood waters contaminated by urine
from infected animals
PATHOGENESIS
Leptospires may enter the host through:
abrasions in the skin or through intact mucous membranes (conjunctiva
and the lining of the oro- and nasopharynx)
Drinking of contaminated water may introduce leptospires through the
mouth, throat, or esophagus.
Can damage the wall of small blood vessels leading to vasculitis with leakage
and extravasation of cells, including hemorrhages.
The most important known pathogenic properties are adhesion to cell
surfaces and cellular toxicity.
Hypovolemia:
due to dehydration
altered capillary permeability may contribute to the development of renal
failure.
Pulmonary involvement
result of hemorrhage inflammation.
Invasion of skeletal muscle
results in swelling, and focal necrosis.
In severe leptospirosis, vasculitis may ultimately impair the microcirculation
and increase capillary permeability, resulting in fluid leakage and
hypovolemia.
When antibodies are formed, leptospires are eliminated from all sites in the
host except:
the eye,
the proximal renal tubules,
the brain, where they may persist for weeks or months.
Renal failure:
during the second week of illness.
Hypovolemia and decreased renal perfusion contribute to the
development of acute tubular necrosis with oliguria or anuria
Manage by Dialysis
Pulmonary involvement
resulting in cough, dyspnea, chest pain, and blood-stained sputum, and
sometimes in hemoptysis or even respiratory failure.
Hemorrhagic manifestations are seen in Weil's syndrome: epistaxis,
petechiae, purpura, and ecchymoses
severe gastrointestinal bleeding and adrenal or subarachnoid hemorrhage are
detected rarely.
severe leptospirosis
Rhabdomyolysis
Hemolysis
Myocarditis
Pericarditis
congestive heart failure
cardiogenic shock
adult respiratory distress syndrome
multiorgan failure
LABORATORY AND RADIOLOGIC FINDINGS
Related findings range from:
urinary sediment changes:
Leukocytes erythrocyteshyaline or granular casts)
mild proteinuria in anicteric leptospirosis
renal failure and azotemia in severe disease.
Treatment
Penicillin
Drug of choice
For severe cases:
intravenous administration of penicillin G, amoxicillin, ampicillin, or
erythromycin.
In milder cases:
oral treatment with tetracycline, doxycycline, ampicillin, or amoxicillin
Other antibiotics:
cephalosporins, are highly active against leptospires in vitro
Patients with severe leptospirosis and renal failure may require dialysis.
Those with Weil's syndrome may need transfusions of whole blood and/or
platelets.
Intensive care may be necessary.
PROGNOSIS
Most patients recover.
Mortality is highest among patients who are elderly and those who have
Weil's syndrome.
Leptospirosis during pregnancy is associated with high fetal mortality
PREVENTION
Individuals who may be exposed to leptospires through their occupations or
their involvement in recreational water activities should be informed about
the risks.
Measures for controlling leptospirosis include avoidance of exposure to urine
and tissues from infected animals, vaccination of animals, and rodent
control. The animal vaccine used in a given area should contain the
serovars known to be present in that area.
Control of Leptospirosis
To remove fluid and uremic waste products from the body when the kidneys
cannot do so
Used to treat patient with edema that does not responds to treatment,
hepatic coma, hyperkalemia, hypertension and uremia
Acute Dialysis:
indicated in high and rising level of serum potassium, fluid overload,
impending pulmonary edema, acidosis, pericarditis
Chronic or maintenance:
indicated in chronic renal failure,ESRD in presence of uremic
signs( nausea, vomiting, severe anorexia,increasing lethargy, mental
confusion) hyperkalemia, fluid overload not responsive to diuretics, fluid
restriction
HEMODIALYSIS
Most commonly used method
Favored in pts ( > 80kg) with no residual renal function.
For ill and requiring short term dialysis and in pt. with ESRD
3 x a wk for atleast 3-4 hrs
Components
DIALYZER: synthetic semipermeable membrane/ artificial kidney, replacing
glomerulus & tubules as the filter
Composition and delivery of dialysate- buffer is usually bicarbonate
Blood delivery system- composed of:
Dialysis machine- blood pump, dialysis solution delivery system
Dialysis access-fistula, graft or catheter through which blood is
obtained for hemodialysis
-complications include thrombosis due to intimal hyperplasia, which
results to stenosis 2 to 3cm proximal to the venous anastomosis
EQUIPMENT
Dialyzers/ artificial kidney
Flat-plate or hollow-fiber: contain thousands of tiny cellophane tubules that
acts as semipermeable membrane
Blood flow through the tubules while a solution(dialysate) circulate around
the tubules.
Exchange of wastes from the blood to the dialysate occurs through
semipermeable membrane tubules
Principles:
Extract toxic nitrogenous substances from the blood, remove excess water
Diffusion, osmosis and ultrafiltration are the principles
Toxin & waste are remove by diffusion using dialysate which is made up
of important electrolyte
Excess water is remove by osmosis
Vascular Access
Subclavian, internal jugular, femoral catheters
circulation for acute hemodialysis is achieved by inserting a double lumen
or multilumen catheter into the access
it can be used for several weeks
catheter are remove when no longer needed
Fistula
More permanent access
Created surgically
Usually in the forearm, by joining an artery to a vein, either side to side
or end to side
Needles are inserted to the vessels to obtain a blood flow adequate to
pass through dialyser
Takes 4-6 wks to mature before it is ready to use
Graft
Arteriovenous
Created by subcutaneously interposing a biologic, semibiologic or
synthetic graft material between artery and vein
Used if patients vessels are not suitable for fistula, patient with
compromised vascular system
Usually placed in the fore artm, upper arm, or upper thigh.
Infection and thrombosis are the most common complication of
arteriovenous graft.
Common
Hypotension
Muscle cramps
Restless legs syndrome
Nausea & vomiting
Headache
Chest & back pain
Pruritus
Fever & chills
Uncommon
Dialysis dysequilibrium
Dialyzer reaction
Arrhythmia
Cardiac tamponade
Intracranial bleeding
Seizures
Hemolysis
Air embolism
Long-term Complications of Hemodialysis
Osteomalacia
Dialysis-induced beta-2 microglobulin
Myopathy
Accelerated atherosclerosis, vascular calcification
Hyperpigmentation
Hepatitis B/C, idiopathic ascites
Leukopenia, hypocomplementemia, bleeding diathesis
PERITONEAL DIALYSIS
Remove toxic substances and metabolic waste and re establish normal fluid
and electrolyte balance
Treatment of choice for patients with renal failure who are unable or
unwilling to undergo hemodialysis or renal transplantation.
PRINCIPLES
Peritoneum a serous membrane that covers the abdominal organs and lines
the abdominal wall, serves as the semipermeable membrane
The of the peritoneum constitute a body surface area of about 22, 000 cm2
Sterile dialysate fluid is introduced into the peritoneal cavity through an
abdominal catheter at intervals.
Urea and creatinine metabolic end products normally excreted by the kidneys
are cleared from blood by diffusion and osmosis as waste products move
from an area of higher concentration to an area of lower concentration
across a semipermeable membrane
Urea is cleared at rate of 15-20mL/min, creatinine is remove at slower rate
Usually takes 36 to 48 hrs. to achieved peritoneal dialysis
PROCEDURE:
Preparing Equipment
cosult the Dr. to determine concentration of dialysate
dialysate warmed to body temperature
Assemble administration set and tubing
diffusion of small molecules, urea, creatinine peaks in the 1st 5-10 minutes
of dwell time
Drainage is usually completed in 10 to 30 minutes
Removal of excess water is achieved by using hypertonic dialysate with high
dextrose concentration that creates an osmotic gradients.
Complications of Peritoneal Dialysis
Catheter
Pain
Bleeding
Leakage
Poor flowPeritonitis
flowPeritonitis
Leakage
Bleeding
Hypertriglyceridemia: long term complication
Acute perforation
Peritonitis
Nutrition
High glucose, protein loss
Hernia
Genital edema
Hydrothorax
Back Pain
Peritoneal fibrosis
*Dialysis does not replace ALL the functions of the kidneys especially those
with long-term significance such as erythropoietin production and Vitamin
D3 synthesis.